Antihypertensive Efficacy and Tolerability and Determine the Adequate Antihypertensive Dosage of Fimasartan in Mild to Moderate Essential Hypertension Patients
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Byung-Hee Oh, Professor
Seoul National University Hospital
Study Chair - Dong-Ju Choi, Professor
Seoul National University Bundang Hospital
Principal Investigator - Eun-Suk Jeon, Professor
Samsung Medical Center
Principal Investigator - Jae-Joong Kim, Professor
Asan Medical Center
Principal Investigator - Jeong-Bae Park, Professor
Cheil General Hospital and Women's Healthcare Center
Principal Investigator - Jong-Won Ha, Professor
Severance Hospital
Principal Investigator - Ki-Bae Seong, Professor
Kangnam ST.Mary's Hospital
Principal Investigator - Se-Joong Lim, Professor
Yonsei University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Seoul National University Hospital
Seoul, South Korea
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Sept 2007
- Primary completion
- 30 Jun 2008
- Completion
- 30 Jun 2008
- Last update posted
- 18 Jun 2009
- Registered enrollment
- 182
- Registry id
- NCT00923611
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.